Johnson & Johnson (J&J) has announced new data showing that Tremfya (guselkumab) reduces symptoms of psoriatic arthritis (PsA ...

Novartis has announced plans to build a new flagship US manufacturing hub in North Carolina. The announcement comes as part ...

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that ...

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led ...

Behavioural science backs this up. Positive emotions like joy enhance creativity, strengthen motivation and boost resilience ...

Havas Lynx CX is tackling this head-on with an approach that puts people at the heart of every decision. We’ve launched three ...

Pharma must respond not defensively, but proactively. It must show up in real time with empathy, credibility and clarity. Staying silent is also not an option – the presumption of today’s public is ...

Aspire was founded on an entrepreneur’s vision to create an agile, entrepreneurial company that was not present in the UK. The founding principle was to take a medicine, a molecule or a device and ...

Merck KGaA has received US FDA Fast Track designation for its generalised myasthenia gravis (gMG) drug treatment. Current ...

The biggest prostate cancer screening trial in decades has been launched in the UK, with the goal of finding the best way to ...

The US Food and Drug Administration (FDA) has approved PADCEV (enfortumab), in combination with Keytruda (pembrolizumab) or ...